IHS Diabetes Audit
Karen Sheff, MS IHS Division of Diabetes Treatment and Prevention March 20, 2019
Tribal Leaders Diabetes Committee Meeting Washington, DC
IHS Diabetes Audit Karen Sheff, MS IHS Division of Diabetes - - PowerPoint PPT Presentation
Tribal Leaders Diabetes Committee Meeting Washington, DC IHS Diabetes Audit Karen Sheff, MS IHS Division of Diabetes Treatment and Prevention March 20, 2019 Todays Audit Topics 1. Introduction 2. History 3. Reports 4. Outcomes 5.
Tribal Leaders Diabetes Committee Meeting Washington, DC
1. Work towards the goal of providing all diabetes patients with the highest quality of care, as outlined in the IHS Diabetes Standards of Care 2. Assess the diabetes care provided at a facility, including strengths and areas for improvement 3. Fulfill requirements of Special Diabetes Program for Indians (SDPI) grants (participation in Annual Audit) 4. Contribute to Area and IHS outcome measures and reports
https://www.ihs.gov/diabetes/clinician-resources/soc/
a. Current year b. Trends over time
a. Each Area b. All Areas combined
a. Stakeholders (including Tribal leaders) b. Others: SDPI Reports to Congress, government and other publications
586 charts were audited from 586 patients on the diabetes registry.
40 80 120 160 200 240 280 320 360 1 9 9 7 1 9 9 8 1 9 9 9 2 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 2 1 2 1 1 2 1 2 2 1 3 2 1 4 2 1 5 2 1 6 2 1 7 2 1 8
# of Facilities Audit Year
Number of Participating Facilities 1997-2018
Source: IHS Diabetes Care and Outcomes Audit
10 20 30 40 50 60 70 80 90 100 110 120 130 1 9 9 7 1 9 9 8 1 9 9 9 2 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 2 1 2 1 1 2 1 2 2 1 3 2 1 4 2 1 5 2 1 6 2 1 7 2 1 8
Number of Charts (1000's) Audit Year
Number of Charts Audited 1997-2018
Source: IHS Diabetes Care and Outcomes Audit
6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 1 9 9 7 1 9 9 8 1 9 9 9 2 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 2 1 2 1 1 2 1 2 2 1 3 2 1 4 2 1 5 2 1 6 2 1 7 2 1 8
Mean A1C (%) Audit Year
Mean A1C 1997-2018
Source: IHS Diabetes Care and Outcomes Audit
60 70 80 90 100 110 120 130 140 150 160 1 9 9 7 1 9 9 8 1 9 9 9 2 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 2 1 2 1 1 2 1 2 2 1 3 2 1 4 2 1 5 2 1 6 2 1 7 2 1 8
Mean BP (mmHG) Audit Year
Mean Blood Pressure 1997-2018
Source: IHS Diabetes Care and Outcomes Audit
Systolic Diastolic
70 80 90 100 110 120 130 140 150 1 9 9 8 1 9 9 9 2 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 2 1 2 1 1 2 1 2 2 1 3 2 1 4 2 1 5 2 1 6 2 1 7 2 1 8
Mean LDL Cholesterol (mg/dl) Audit Year
Mean LDL Cholesterol 1998-2018
Source: IHS Diabetes Care and Outcomes Audit
10 20 30 40 50 60 70 80 90 100 1 9 9 7 1 9 9 8 1 9 9 9 2 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 2 1 2 1 1 2 1 2 2 1 3 2 1 4 2 1 5 2 1 6 2 1 7 2 1 8
% Patients Audit Year
Education 1997-2018
DM Nutrition Physical Activity Any DM Education
Source: IHS Diabetes Care and Outcomes Audit
10 20 30 40 50 60 70 80 90 100 2 9 2 1 2 1 1 2 1 2 2 1 3 2 1 4 2 1 5 2 1 6 2 1 7 2 1 8
% Patients Audit Year
CKD Stage Excluding Unknown (Age ≥18) 2009-2018
Normal Stage1 or 2 Stage3 Stage4 Stage5
Normal: eGFR=>60 & UACR<30 Stage 1 & 2: eGFR=>60 & UACR=>30 Stage 3: eGFR 30-59 Stage 4: eGFR 15-29 Stage 5: eGFR <15
Source: IHS Diabetes Care and Outcomes Audit
10 20 30 40 50 60 70 80 90 100 2 1 3 2 1 4 2 1 5 2 1 6 2 1 7 2 1 8
% Patients Audit Year
Diagnosed CVD and Antiplatelet and Statin Medication 2013-2018
Of patients with CVD dx, antiplatelet therapy prescribed Of patients with CVD dx, statin prescribed CVD dx
Source: IHS Diabetes Care and Outcomes Audit